ICCM ICECURE MED LTD revenue, earnings and financials

For the fiscal year ended December 2025 revenue was $3.38M, up 2.7% on the year before.

ICCM annual revenue and earnings

Fiscal year ended Dec 2025: revenue $3.38M, gross profit $1.23M, operating income −$15.1M, net income −$15.1M (margin -445.6%), EPS $0.24
Fiscal year ended Dec 2024: revenue $3.29M, gross profit $1.45M, operating income −$15.7M, net income −$15.3M (margin -465.5%), EPS $0.30
Fiscal year ended Dec 2023: revenue $3.23M, gross profit $1.30M, operating income −$15.6M, net income −$14.7M (margin -453.8%), EPS $0.32
Fiscal year ended Dec 2022: revenue $3.09M, gross profit $1.45M, operating income −$16.7M, net income −$17.0M (margin -550.3%), EPS $0.46
Fiscal year ended Dec 2021: revenue $4.14M, gross profit $2.20M, operating income −$9.72M, net income −$9.90M (margin -239.1%), EPS $0.35

Dec 31, 2025: cash $8.90M, total assets $13.9M, total liabilities n/a, shareholders' equity $9.05M, long-term debt $13.0K
Jun 30, 2025: cash $5.38M, total assets $10.6M, total liabilities $7.70M, shareholders' equity $2.89M, long-term debt $59.0K
Dec 31, 2024: cash $7.56M, total assets $12.6M, total liabilities $5.68M, shareholders' equity $6.90M, long-term debt $161K
Jun 30, 2024: cash $9.65M, total assets $15.4M, total liabilities $4.75M, shareholders' equity $10.6M
Dec 31, 2023: cash $10.5M, total assets $16.4M, total liabilities $4.25M, shareholders' equity $12.2M
Jun 30, 2023: cash $3.03M, total assets $22.7M, total liabilities $4.25M, shareholders' equity $18.4M
Dec 31, 2022: cash $23.7M, total assets $30.2M, total liabilities $4.77M, shareholders' equity $25.4M
Jun 30, 2022: cash $13.5M, total assets $23.8M, total liabilities $4.94M, shareholders' equity $18.9M

ICECURE MED LTD reported $3.38M of revenue for the fiscal year ended December 2025.

No. ICECURE MED LTD lost $15.1M in its latest fiscal year.